(6.2.8)-蛋白純化策略生物化學(xué)實(shí)驗(yàn)_第1頁(yè)
(6.2.8)-蛋白純化策略生物化學(xué)實(shí)驗(yàn)_第2頁(yè)
(6.2.8)-蛋白純化策略生物化學(xué)實(shí)驗(yàn)_第3頁(yè)
(6.2.8)-蛋白純化策略生物化學(xué)實(shí)驗(yàn)_第4頁(yè)
(6.2.8)-蛋白純化策略生物化學(xué)實(shí)驗(yàn)_第5頁(yè)
已閱讀5頁(yè),還剩23頁(yè)未讀 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶(hù)提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

1Developinganefficientproteinpurificationscheme2IntroductionThreephasestrategyCombiningtechniquesPurityrequirementsCharacteristicsofthetargetproteinandcontaminantsExamplesSummaryandshortcutsDevelopinganefficientproteinpurificationscheme3ProteinPurification-AimsSufficientpurityandquantityMaintainedbiologicalactivityGoodeconomy4YieldsfromMultistepProteinPurificationsNumberofstepsYield(%)95%/step90%/step85%/step80%/step75%/step020406080100123456785InputforPurificationProtocolDevelopment

ThreephasestrategyPurificationprotocolRequiredpurityandquantityPhysical-chemicalpropertiesoftargetandmaincontaminantsSourcematerialinformationSeparationtechniqueknowledgeScoutingrunsandoptimizationEconomyandresources6ProteinPurificationAnalyticaltoolsArapidandreliableassayforthetargetproteinPuritydetermination

(e.g.SDS)Totalproteindetermination

(e.g.colorimetricmethod)7ThreePhaseStrategyPurityStepCaptureIntermediatepurificationPolishingIsolateproduct,concentrate,stabilizeRemovebulkimpuritiesAchievefinalpurity.Removetraceimpurities,structuralvariants,aggregatesetc.8Capture

ResolutionSpeedRecoveryCapacityInitialpurificationofthetargetmoleculefromcrudeorclarified sourcematerial

Concentrationandstabilization(e.g.removalofproteases)9IntermediatePurification

ResolutionSpeedRecoveryCapacity

Removalofbulkimpurities10Polishing

ResolutionSpeedRecoveryCapacity

Finalremovaloftracecontaminants,e.g.structuralvariantsof thetargetprotein

11ThreePhaseStrategy-RankingofChromatographyTechniques

Technique Capture Intermediate Polishing

GF

IEX

HIC AC

RPC

ConsiderationsLimitedsamplevolumeLimitedflowraterangeProteinligandissensitivetoharshcleaningconditionsUseoforganicsolvents,lossofbiologicalactivity12LinkingChromatographyTechniquesintoaPurificationProtocol-GeneralRulesCombinetechniqueswithcomplementaryselectivities(e.g.IEX,HICandGF).

Minimizesamplehandlingbetweenpurificationsteps(e.g.concentration,bufferexchange).

13LinkingChromatographyTechniquesTechniqueEndconditionsStartconditionsSmallsamplevolumeGFDilutedsampleBufferchange(ifrequired)LowionicstrengthIEXHighionicstrengthor

pHchangeHighionicstrengthHICLowionicstrengthSpecificbindingconditionsACSpecificelutionconditions14LinkingChromatographyTechniques

1.IEX HIC GF 2.AC GF

RPC IEX 3.HIC GF AC GF4.(NH4)2SO4 HIC IEX GF HIC GF IEX5.GF GF(desalting) AC GF15PurityRequirements Contaminantswhichdegradeorinactivatethetargetprotein(e.g. proteases),needtobereducedto“non-detectable”levels.

Contaminantswhichinterferewithsubsequentanalysesneedto bereducedto“non-detectable”levels.

Itisbetterto“over-purify”thanto“under-purify”.16Therapy

Invivostudies Crystallizationforx-raystudies N-terminalsequencing ofanunknownprotein Mostphysical-chemicalcharacterizationmethods Antigenformonoclonal antibodyproductionExtremelyhighHighModeratePurityRequirements-BriefGuidelines17TowardstheOptimalPurificationProtocol-AccountingforTargetProteinProperties(1)Targetproteinproperty

PurificationparameteraffectedStabilitywindowpHIonicstrengthCo-factorsDetergentconcentrationOrganicsolventsOther(light,oxygenetc.)IEXconditions(alsoACandRPC)HICconditionsselectionofbuffers,pH,salts,additivesbufferadditivesRPCconditionsvarious18TowardstheOptimalPurificationProtocol-AccountingforTargetProteinProperties(2)Physical-chemicalpropertiesChargeproperties(isoelectricpoint)MolecularweightPost-translationalmodificationsBiospecificaffinityTargetproteinproperty

PurificationparameteraffectedselectionofIEXconditionsselectionofGFmediumselectionofgroupspecificACmediumselectionofligandforAC19TargetProteinStabilityWindowDeterminationofasuitableammoniumsulfateconcentrationandpHscreeningrangeforHIC20TargetProteinProperties

Selectionofionexchangeconditions05678pHmoleculescharge+-Electrophoretictitrationcurveofchickenbreastmuscle

usingzymogramdetectionforcreatinekinaseTargetproteinContaminants21GProteinReceptorKinasePurificationTechniquePptHICAIEXCIEXACPurification

factorComment720240818647

Allbufferscontain

proteaseinhibitors Allpurificationsdoneat+4oC

Removalstep,main

contaminantisbound

Elutionbufferisusedas startingbufferfornextcolumn 10mghomogenousprotein

obtainedA.Tobinetal.(1996)J.Biol.Chem.271,3907-3916PorcinecerebellahomogenateRESOURCEQAmmoniumsulfate

precipitationButylSepharoseFastFlowRESOURCEsHiTrapHeparin22Reca-MannosidasePurificationfromPichiaTechniquePurification

factorComment 83mghomogenousprotein

obtainedY.-F.Liaoetal.(1996)J.Biol.Chem.271,28348-28358Capturewithstepgradient;

730mgoftotalproteinapplied63622719UFGFAIEXHICPhenylSepharoseHPQSepharoseFFSuperdex200pgUltrafiltration23DNABindingProteinPurificationTechniqueDNA-1SepharoseCIEXACACACCIEXPurification

factorComment584943 GeneralACstepforDNA

bindingproteins Removalstep,non-specific

DNAbindingactivityremovedMainpurificationstep Finalpolishing,20mgprotein

obtainedJ.Berthelsenetal.(1996)

J.Biol.Chem.271,3822-383092447 RapidcaptureHeLacellnuclear

extractsSPSepharoseHighPerformanceHeparinSepharose

FastFlowDNA-2SepharoseMonoS24

Finalpolishingandpuritycheck,

20mgobtainedMembraneProteinPurificationTechniqueACAIEXCIEXACCIEXPurification

factorComment341442

Negativestep;contaminant removed

Detergentexchange,volume

reductionbeforeAC

MainpurificationstepT.Whiteetal.(1995)

J.Biol.Chem.270,24156-241656242

Stepgradient,rapidconcentrating

capturestepPlacentaextractin

1.5%TritonX-100BlueSepharoseDEAESephacelSPSepharoseFFMuc2SepharoseMonoS25TowardsaGeneralProteinPurificationProtocolArapidmethodforobtainingmilligramquantitiesofdifferentrecombinantproteins,forinitialcharacterizationstudiesSemi-automatedin?KTAexplorer,withpre-mademethodtemplatesandBufferPrepIonexchangeSTREAMLINESPorDEAESPorQSepharoseFFHydrophobicinteractionPhenylSepharoseFF(highsub)GelfiltrationSuperdex75prepgrade26TowardsaGeneralProteinPurificationProtocol-ResultswithE.colir-ProteinsIonexchangeSTREAMLINESPorDEAESPorQSepharoseFFHydrophobicinteractionPhenylSepharoseFF(highsub)GelfiltrationSuperdex75prepgradeProtein Expression Capturestep(purifiedtohomogeneity)

AnnexinV Extracellular STREAMLINEDEAEa-Amylase Intracellular STREAMLINEDEAEanti-gp120Fab Periplasmic SPSepharoseFastFlow

27Shortcuts-RapidEstablishmentofMilligramScalePurificationProtocolsIfabiospecificligandisavailable:

useACasthemainpur

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶(hù)所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶(hù)上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶(hù)上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶(hù)因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論